Outcome and Risk Factors for Mortality in Peritoneal Dialysis Patients: 22 Years of Experience in a Turkish Center

被引:0
作者
Demir, Erol [1 ]
Caliskan, Yasar [2 ,3 ]
Goksoy, Yagmur [4 ]
Sacli, Fadime Sevgi [5 ]
Mutlu, Ummu [6 ]
Turkmen, Aydin [3 ]
Bozfakioglu, Semra [3 ]
机构
[1] Koc Univ Hosp, Koc Univ, Transplant Immunol Res Ctr Excellence, Istanbul, Turkiye
[2] St Louis Univ Hosp, St Louis Univ, Dept Internal Med, Div Nephrol, St Louis, MO USA
[3] Istanbul Univ, Fac Med, Dept Internal Med, Div Nephrol, Istanbul, Turkiye
[4] Istanbul Univ, Fac Med, Dept Internal Med, Istanbul, Turkiye
[5] Hlth Sci Univ Okmeydani Training & Res Hosp, Dept Nephrol, Istanbul, Turkiye
[6] Istanbul Univ, Dept Internal Med, Div Endocrinol, Fac Med, Istanbul, Turkiye
来源
TURKISH JOURNAL OF NEPHROLOGY | 2024年 / 33卷 / 02期
关键词
Chronic kidney diseases; peritoneal dialysis; mortality; PERMEABILITY; UPDATE; TURKEY;
D O I
10.5152/turkjnephrol.2024.22491
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: European peritoneal dialysis populations have identified and reported mortality and morbidity risk factors. However, no reports are pointing out the factors affecting the outcomes of these patients during more than 2 decades of follow-up in T & uuml;rkiye. This single -center study aims to evaluate patient mortality and peritonitis rates and estimate confounding factors affecting patient mortality over 22 years. Methods: Adult patients who underwent peritoneal dialysis at our center between December 1994 and December 2016 were enrolled in this retrospective cohort study. The primary outcome of the present study was mortality, and the secondary outcomes were technical failure and peritonitis. Results: Two hundred fifty patients were included in this study. The patients were followed up for a median of 39.5 months (range 17-71). Forty-eight (19.2%) patients died. Survival rates at 5, 10, and 15 years were 86.8% (217/250), 64.6% (86/133), and 41.1% (30/73), respectively. The prevalence of diabetes mellitus [14 (29.2%) vs. 20 (9.9%); P < .001] and cardiovascular disease [16 (33.3%) vs. 24 (11.9%); P < 0.001] were significantly higher in the deceased group compared to the survival group. Cardiovascular disease was the leading cause of death [26 (54.1%)]. Age (hazard ratio (HR) 1.06; 95% CI, 1.04-1.09; P < .001), male sex (HR 2.07; 95% CI, 1.10-3.90; P = .024), and transfer to peritoneal dialysis due to vascular access problems (HR 3.91; 95% CI, 1.90-8.07; P < .001) were associated with mortality in multivariate analysis. Also, catheter exit -site infection, peritonitis rate, catheter removal, and technical complications were similar between the groups. The peritonitis rate was 0.2 episodes per patient per year. Conclusion: The mortality rate of the patient population in our center was similar to Europe and the United States. Cardiovascular diseases and diabetes are the leading causes of death in Turkish peritoneal dialysis patients, as in other populations.
引用
收藏
页数:129
相关论文
共 50 条
  • [41] Analysis of risk factors for refractory peritonitis in patients undergoing peritoneal dialysis
    Yuan, Dan
    Sun, Zhenxing
    Shi, Yanan
    Zhou, Jingjing
    Shi, Chunxia
    Li, Zhongxin
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (08): : 3832 - 3841
  • [42] Comparison of risk factors for cardiovascular disease in hemodialysis and peritoneal dialysis patients
    Harmankaya, Ozlem
    Akalin, Nilgul
    Akay, Hatice
    Okuturlar, Yildiz
    Erturk, Kayhan
    Kaptanogullari, Hakan
    Kocoglu, Hakan
    CLINICS, 2015, 70 (09) : 601 - 605
  • [43] Health-related quality of life, depression and mortality in peritoneal dialysis patients in Turkey: seven-year experience of a center
    Turkmen, Kultigin
    Guney, Ibrahim
    Yazici, Raziye
    Arslan, Sevket
    Altintepe, Lutfullah
    Yeksan, Mehdi
    RENAL FAILURE, 2014, 36 (06) : 859 - 864
  • [44] Risk factors of severe peritoneal sclerosis in chronic peritoneal dialysis patients
    Alatab, Sudabeh
    Najafi, Iraj
    Pourmand, Gholamreza
    Hosseini, Mostafa
    Shekarchian, Soroosh
    RENAL FAILURE, 2017, 39 (01) : 32 - 39
  • [45] Peritoneal protein clearance predicts mortality in peritoneal dialysis patients
    Lu, Wanhong
    Pang, Wing-Fai
    Jin, Li
    Li, Huixian
    Chow, Kai Ming
    Kwan, Bonnie Ching-Ha
    Leung, Chi Bon
    Li, Philip Kam-Tao
    Szeto, Cheuk Chun
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2019, 23 (04) : 551 - 560
  • [46] THE IMPACT OF TIMING OF DIALYSIS INITIATION ON MORTALITY IN PATIENTS WITH PERITONEAL DIALYSIS
    Kim, Hyung Wook
    Kim, Su-Hyun
    Kim, Young Ok
    Jin, Dong Chan
    Song, Ho Chul
    Choi, Euy Jin
    Kim, Yong-Lim
    Kim, Yon-Su
    Kang, Shin-Wook
    Kim, Nam-Ho
    Yang, Chul Woo
    Kim, Yong Kyun
    PERITONEAL DIALYSIS INTERNATIONAL, 2015, 35 (07): : 703 - 711
  • [47] Peritoneal protein clearance predicts mortality in peritoneal dialysis patients
    Wanhong Lu
    Wing-Fai Pang
    Li Jin
    Huixian Li
    Kai Ming Chow
    Bonnie Ching-Ha Kwan
    Chi Bon Leung
    Philip Kam-Tao Li
    Cheuk Chun Szeto
    Clinical and Experimental Nephrology, 2019, 23 : 551 - 560
  • [48] Neutrophil Percentage-to-Albumin Ratio and Risk of Mortality in Patients on Peritoneal Dialysis
    Yu, Yi
    Zhong, Zhong
    Yang, Wenzhuo
    Yu, Jianwen
    Li, Jianbo
    Guo, Xingdi
    Chen, Jiasi
    Mao, Haiping
    Li, Zhijian
    JOURNAL OF INFLAMMATION RESEARCH, 2023, 16 : 6271 - 6281
  • [49] Epidemiological Characteristics and Mortality Risk Factors Comparison in Dialysis and Non-Dialysis CKD Patients with COVID-19-A Single Center Experience
    Niculae, Andrei
    Peride, Ileana
    Nechita, Ana-Maria
    Petcu, Lucian Cristian
    Tiglis, Mirela
    Checherita, Ionel Alexandru
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (06):
  • [50] Abnormal iron status is associated with an increased risk of mortality in patients on peritoneal dialysis
    Luo, Dan
    Zhong, Zhong
    Qiu, Yagui
    Wang, Yating
    Li, Hongyu
    Lin, Jianxiong
    Chen, Wei
    Yang, Xiao
    Mao, Haiping
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2021, 31 (04) : 1148 - 1155